
GC11214
Ipatasertib
Also listed as GDC-0068 (RG7440)
GDC-0068 (RG7440, Ipatasertib) is a novel highly selective ATP-competitive pan-Akt inhibitor that inhibits all three isoforms of Akt1, Akt2, and Akt3 at an IC50 of 5,18,8 nM, respectively
ChemicalCAS1001264-89-6MW458FormulaC24H32ClN5O2
- CAS number
- 1001264-89-6
- Molecular weight
- 458
- Formula
- C24H32ClN5O2
- Solubility
- ≥ 22·9mg/mL in DMSO
- InChIKey
- GRZXWCHAXNAUHY-NSISKUIASA-N
- Catalogue number
- GC11214
- Brand
- GLPBIO
Computed properties PubChem CID 24788740 · XLogP 2.5 · TPSA 81.6 Ų · H-bond donors 2
- XLogP
- 2.5
- TPSA
- 81.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 32
SMILES C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O
Computed descriptors from PubChem (CID 24788740), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il